查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
胃肠药物全球市场：按类型、药物类别、给药途径、应用、分销渠道、地区 - 规模、份额、展望、机会分析，2022-2030 年
市场调查报告书
商品编码
1233340

胃肠药物全球市场：按类型、药物类别、给药途径、应用、分销渠道、地区 - 规模、份额、展望、机会分析，2022-2030 年

Digestive Drugs Market, By Type, By Drug Class, By Route of Administration, By Application, By Distribution Channel, And by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3个工作天内

价格
简介目录

胃肠药物用于缓解消化系统症状，尤其是胃酸反流、消化不良和肠易激综合征 (IBS)。 它还用于治疗其他严重疾病，如克罗恩病、溃疡性结肠炎和食管裂孔疝。 常见的消化问题包括腹痛、腹胀、腹泻、便秘和胃灼热。 有用于治疗各种消化系统疾病的消化疗法。 例如，胃酸反流和消化不良可用雷尼替丁和奥美拉唑等抗酸剂治疗。 更严重的病症，如溃疡性结肠炎和克罗恩病，用布地奈德、美沙拉秦和泼尼松龙等药物治疗。 生产胃肠药的大公司只有艾伯维、Alexion Pharmaceuticals、葛兰素史克、Ironwood Pharmaceuticals 和 Janssen Pharmaceuticals 等几家。

市场动态

进入胃肠药市场的公司不断推出新药，这有助于胃肠药市场的增长。 例如，2022 年 7 月，总部位于韩国的製药公司 JW Pharmaceutical 推出了一种联合消化药物 Besticon。 它由阿尔维林柠檬酸盐、西甲硅油和解痉药组成。 Besticon 对患有肠易激综合症、消化不良等胃肠道问题的患者有效。 同样，2021 年 5 月，跨国製药公司百时美施贵宝 (Bristol-Myers Squibb) 获得美国食品药品监督管理局 (FDA) 批准 Zeposia 用于治疗严重活动性溃疡性结肠炎 (UC)。 该药物是一种鞘氨醇 1-磷酸 (S1P) 受体调节剂，可抑制淋巴细胞迁移至肠道。

这项研究的主要特点

  • 本报告对全球胃肠药物市场进行了深入分析，以 2021 年为基准年，提供了预测期（2022-2030 年）的市场规模（美国）和復合年增长率 (CAGR%)。发布。
  • 它揭示了各个细分市场的潜在收入机会，并描述了该市场具有吸引力的投资建议矩阵。
  • 它还提供有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争策略的重要见解。
  • 它根据以下参数介绍了全球胃肠病学市场的领先企业，包括公司亮点、产品组合、主要亮点、财务业绩和战略。
  • 本研究涵盖的主要公司包括：葛兰素史克公司、艾伯维公司（艾尔建）、武田製药有限公司、辉瑞公司、阿斯利康公司、Marksans Pharma、Tillotts Pharma AG、Salix Pharmaceuticals 和 Otsuka Pharmaceutical Co., Ltd ., Merck & Co., Inc., Lexicon Pharmaceuticals, Inc., Bayer AG, Cadila Healthcare Ltd.
  • 胃肠药物全球市场报告面向行业内的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
  • 利益相关者可以通过用于分析全球胃肠药物市场的各种战略矩阵来促进他们的决策。

内容

第 1 章目的和先决条件

  • 调查目的
  • 先决条件
  • 缩写说明

第 2 章市场概述

  • 报告内容
    • 市场定义和范围
  • 执行摘要
    • 市场概况：按类型分类
    • 市场概况：按药物类别
    • 按给药途径划分的市场概况
    • 市场概况：按应用分类
    • 市场概况：按分销渠道
    • 市场概况：按地区
  • 连贯机会图 (COM)

第 3 章市场动态、法规和趋势分析

  • 市场动态
    • 司机
    • 约束因素
    • 机会
  • 影响分析
  • 主要发展
  • 监管场景
  • 市场趋势
  • 新产品发布
  • 监管场景
  • PORTER 的五力分析
  • 业务发展战略
  • 流行病学
  • 疾病意识计划
  • 治疗安全性和疗效分析
  • 管道解析

第 4 章全球胃肠药物市场-冠状病毒 (COVID-19) 大流行的影响

  • 对医疗保健的总体影响
  • 对消化道药物生产及其市场需求的影响
  • COVID-19 流行病学

第 5 章全球胃肠病学市场，按类型，2017-2030

  • 品牌化
  • 通用的

第 6 章全球胃肠药物市场，按药物类别，2017-2030

  • 5-氨基水杨酸盐
  • 胃肠道兴奋剂
  • 泻药 (Lux
  • 抗酸剂
  • H2拮抗剂
  • 止泻药
  • 其他

第 7 章按给药途径划分的全球胃肠药物市场，2017-2030

  • 口语
  • 静脉给药
  • 其他

第 8 章全球胃肠病学市场：按应用分类，2017-2030

  • 胃食管反流病 (GERD)
  • 肠易激综合征
  • 溃疡性结肠炎
  • 其他（慢性腹泻、便秘等）

第 9 章全球胃肠药物市场（按分销渠道），2017-2030

  • 医院药房
  • 零售药房
  • 在线药店

第 10 章全球胃肠药物市场，按地区划分，2017-2030

  • 北美
  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲地区
  • 欧洲
  • 英国
  • 德国
  • 法国
  • 意大利
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 韩国
  • 东盟
  • 其他亚太地区
  • 中东
  • 海湾合作委员会
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中非
  • 南非

第11章竞争格局

  • 市场份额分析
    • GlaxoSmithKline plc
    • AbbVie Inc.（Allergan）
    • Takeda Pharmaceutical Company Limited
    • Pfizer Inc
    • AstraZeneca plc
    • Marksans Pharma
    • Tillotts Pharma AG
    • Salix Pharmaceuticals
    • Otsuka Pharmaceutical Co., Ltd.
    • Merck & Co., Inc.
    • Lexicon Pharmaceuticals, Inc.
    • Bayer AG
    • Cadila Healthcare Ltd.

第12章章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5542

Digestive drugs are used to relieve gastrointestinal symptoms such as acid reflux, indigestion, and irritable bowel syndrome (IBS) among others. In addition, it is also used to treat other severe conditions such as Crohn's disease, ulcerative colitis, and hiatal hernia. The common digestive system diseases include symptoms such as abdominal pain, bloating, diarrhoea, constipation and heartburn. There are various gastrointestinal therapeutics that are used for treating various gastrointestinal conditions. For instance, acid reflux and indigestion are treated with antacids such as ranitidine and omeprazole. More severe conditions like ulcerative colitis and Crohn's disease are treated with medications such as budesonide, mesalazine and prednisolone. Few key market players manufacturing gastrointestinal drugs includes AbbVie, Alexion Pharmaceuticals, GlaxoSmithKline, Ironwood Pharmaceuticals and Janssen Pharmaceuticals among others.

Market Dynamics

Companies operating in digestive drugs market are launching new drugs which is contributing to growth of the digestive drugs market. For instance, in July 2022, JW Pharmaceutical, a South Korea based pharmaceutical company, launched Besticon a compound digestive medicine. It is composed of alverine citrate, simethicone and antispasmodic agent. Besticon is effective for patients suffering with irritable bowel syndrome, indigestion and other gastrointestinal issues. Similarly, in May 2021, Bristol Myers Squibb, a multinational pharmaceutical company received the U.S. Food and Drug Administration (FDA) approval for Zeposia for the treatment of severely active ulcerative colitis (UC). It is a sphingosine 1-phosphate (S1P) receptor modulator which reduces lymphocyte migration into the intestines.

Key features of the study:

  • This report provides an in-depth analysis of the global digestive drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global digestive drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
  • Key companies covered as a part of this study include GlaxoSmithKline plc, AbbVie Inc. (Allergan), Takeda Pharmaceutical Company Limited, Pfizer Inc, AstraZeneca plc, Marksans Pharma, Tillotts Pharma AG, Salix Pharmaceuticals, Otsuka Pharmaceutical Co., Ltd., Merck & Co., Inc., Lexicon Pharmaceuticals, Inc., Bayer AG, Cadila Healthcare Ltd.
  • Global digestive drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global digestive drugs market

Detailed Segmentation:

  • Global Digestive Drugs Market, By Type
    • Branded
    • Generic
  • Global Digestive Drugs Market, By Drug Class
    • 5-aminosalicylates
    • GI stimulants
    • Laxatives
    • Antacids
    • H2 Antagonists
    • Antidiarrheals
    • Others
  • Global Digestive Drugs Market, By Route of Administration
    • Oral
    • Intravenous
    • Others
  • Global Digestive Drugs Market, By Application
    • Gastroesophageal Reflux Disease (GERD)
    • Irritable Bowel Syndrome
    • Ulcerative Colitis
    • Others (Chronic diarrhoea, constipation etc.)
  • Global Digestive Drugs Market, By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Digestive Drugs Market, By Region:
    • North America
      • By Country
    • U.S.
    • Canada
    • Latin America
      • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • GlaxoSmithKline plc*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • AbbVie Inc. (Allergan)
    • Takeda Pharmaceutical Company Limited
    • Pfizer Inc
    • AstraZeneca plc
    • Marksans Pharma
    • Tillotts Pharma AG
    • Salix Pharmaceuticals
    • Otsuka Pharmaceutical Co., Ltd.
    • Merck & Co., Inc.
    • Lexicon Pharmaceuticals, Inc.
    • Bayer AG
    • Cadila Healthcare Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Drug Class
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Application
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Market Trends
  • New Product Launches
  • Regulatory Scenario
  • PORTER's Five Forces Analysis
  • Business Development Strategies
  • Epidemiology
  • Disease Awareness Programs
  • Treatment Safety and Efficacy Analysis
  • Pipeline Analysis

4. Global Digestive Drugs Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact on Healthcare
  • Impact on Digestive Drugs Manufacturing and Its Market Demand
  • COVID-19 Epidemiology

5. Global Digestive Drugs Market, By Type, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Branded
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Generic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

6. Global Digestive Drugs Market, By Drug Class, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • 5-aminosalicylates
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • GI stimulants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Laxatives
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Antacids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • H2 Antagonists
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Antidiarrheals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

7. Global Digestive Drugs Market, By Route of Administration, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

8. Global Digestive Drugs Market, By Application, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Gastroesophageal Reflux Disease (GERD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Irritable Bowel Syndrome
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Ulcerative Colitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Others (Chronic diarrhoea, constipation etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

9. Global Digestive Drugs Market, By Distribution Channel, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)

10. Global Digestive Drugs Market, By Region, 2017 - 2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Mn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Mn)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

11. Competitive Landscape

  • Market Share Analysis
    • GlaxoSmithKline plc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • AbbVie Inc. (Allergan)
    • Takeda Pharmaceutical Company Limited
    • Pfizer Inc
    • AstraZeneca plc
    • Marksans Pharma
    • Tillotts Pharma AG
    • Salix Pharmaceuticals
    • Otsuka Pharmaceutical Co., Ltd.
    • Merck & Co., Inc.
    • Lexicon Pharmaceuticals, Inc.
    • Bayer AG
    • Cadila Healthcare Ltd.
  • Analyst Views

12. Section

  • Research Methodology
  • About us